These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 19217025)

  • 1. Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride.
    Narendran R; Frankle WG; Mason NS; Rabiner EA; Gunn RN; Searle GE; Vora S; Litschge M; Kendro S; Cooper TB; Mathis CA; Laruelle M
    Synapse; 2009 Jun; 63(6):447-61. PubMed ID: 19217025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No effect of dopamine depletion on the binding of the high-affinity D 2/3 radiotracer [11C]FLB 457 in the human cortex.
    Frankle WG; Mason NS; Rabiner EA; Ridler K; May MA; Asmonga D; Chen CM; Kendro S; Cooper TB; Mathis CA; Narendran R
    Synapse; 2010 Dec; 64(12):879-85. PubMed ID: 20506387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of dopamine D₂/₃ specific binding in the cerebellum for the positron emission tomography radiotracer [¹¹C]FLB 457: implications for measuring cortical dopamine release.
    Narendran R; Mason NS; Chen CM; Himes M; Keating P; May MA; Rabiner EA; Laruelle M; Mathis CA; Frankle WG
    Synapse; 2011 Oct; 65(10):991-7. PubMed ID: 21360596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproducibility of post-amphetamine [11C]FLB 457 binding to cortical D2/3 receptors.
    Narendran R; Himes M; Mason NS
    PLoS One; 2013; 8(9):e76905. PubMed ID: 24098812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography imaging of dopamine D₂/₃ receptors in the human cortex with [¹¹C]FLB 457: reproducibility studies.
    Narendran R; Mason NS; May MA; Chen CM; Kendro S; Ridler K; Rabiner EA; Laruelle M; Mathis CA; Frankle WG
    Synapse; 2011 Jan; 65(1):35-40. PubMed ID: 20506186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of d-amphetamine on extrastriatal dopamine D2/D3 receptors: a randomized, double-blind, placebo-controlled PET study with [11C]FLB 457 in healthy subjects.
    Aalto S; Hirvonen J; Kaasinen V; Hagelberg N; Kajander J; Någren K; Seppälä T; Rinne JO; Scheinin H; Hietala J
    Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):475-83. PubMed ID: 18985345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging dopamine transmission in the frontal cortex: a simultaneous microdialysis and [11C]FLB 457 PET study.
    Narendran R; Jedema HP; Lopresti BJ; Mason NS; Gurnsey K; Ruszkiewicz J; Chen CM; Deuitch L; Frankle WG; Bradberry CW
    Mol Psychiatry; 2014 Mar; 19(3):302-10. PubMed ID: 23439486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-affinity dopamine D2/D3 PET radioligands 18F-fallypride and 11C-FLB457: a comparison of kinetics in extrastriatal regions using a multiple-injection protocol.
    Vandehey NT; Moirano JM; Converse AK; Holden JE; Mukherjee J; Murali D; Nickles RJ; Davidson RJ; Schneider ML; Christian BT
    J Cereb Blood Flow Metab; 2010 May; 30(5):994-1007. PubMed ID: 20040928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reference region modeling approaches for amphetamine challenge studies with [11C]FLB 457 and PET.
    Sandiego CM; Gallezot JD; Lim K; Ropchan J; Lin SF; Gao H; Morris ED; Cosgrove KP
    J Cereb Blood Flow Metab; 2015 Mar; 35(4):623-9. PubMed ID: 25564239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of methylphenidate-induced change in extrastriatal dopamine concentration using [11C]FLB 457 PET.
    Montgomery AJ; Asselin MC; Farde L; Grasby PM
    J Cereb Blood Flow Metab; 2007 Feb; 27(2):369-77. PubMed ID: 16685253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small effect of dopamine release and no effect of dopamine depletion on [18F]fallypride binding in healthy humans.
    Cropley VL; Innis RB; Nathan PJ; Brown AK; Sangare JL; Lerner A; Ryu YH; Sprague KE; Pike VW; Fujita M
    Synapse; 2008 Jun; 62(6):399-408. PubMed ID: 18361438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans.
    Riccardi P; Li R; Ansari MS; Zald D; Park S; Dawant B; Anderson S; Doop M; Woodward N; Schoenberg E; Schmidt D; Baldwin R; Kessler R
    Neuropsychopharmacology; 2006 May; 31(5):1016-26. PubMed ID: 16237395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of PET studies with the very high-affinity dopamine D2/D3 receptor ligand [11C]FLB 457: re-evaluation of the validity of using a cerebellar reference region.
    Asselin MC; Montgomery AJ; Grasby PM; Hume SP
    J Cereb Blood Flow Metab; 2007 Feb; 27(2):378-92. PubMed ID: 16736043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [18F]Fallypride PET measurement of striatal and extrastriatal dopamine D 2/3 receptor availability in recently abstinent alcoholics.
    Rominger A; Cumming P; Xiong G; Koller G; Böning G; Wulff M; Zwergal A; Förster S; Reilhac A; Munk O; Soyka M; Wängler B; Bartenstein P; la Fougère C; Pogarell O
    Addict Biol; 2012 Mar; 17(2):490-503. PubMed ID: 22023291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.
    Ginovart N; Galineau L; Willeit M; Mizrahi R; Bloomfield PM; Seeman P; Houle S; Kapur S; Wilson AA
    J Neurochem; 2006 May; 97(4):1089-103. PubMed ID: 16606355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of lorazepam on extrastriatal dopamine D(2/3)-receptors-A double-blind randomized placebo-controlled PET study.
    Vilkman H; Kajander J; Aalto S; Vahlberg T; Någren K; Allonen T; Syvälahti E; Hietala J
    Psychiatry Res; 2009 Nov; 174(2):130-7. PubMed ID: 19846281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous competition against binding of [(18)F]DMFP and [(18)F]fallypride to dopamine D(2/3) receptors in brain of living mouse.
    Rominger A; Wagner E; Mille E; Böning G; Esmaeilzadeh M; Wängler B; Gildehaus FJ; Nowak S; Bruche A; Tatsch K; Bartenstein P; Cumming P
    Synapse; 2010 Apr; 64(4):313-22. PubMed ID: 19957365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure to detect amphetamine-induced dopamine release in the cortex with [
    Gertler J; Tollefson S; Jordan R; Himes ML; Mason NS; Frankle WG; Narendran R
    Synapse; 2018 Sep; 72(9):e22037. PubMed ID: 29876970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756.
    Abi-Dargham A; Simpson N; Kegeles L; Parsey R; Hwang DR; Anjilvel S; Zea-Ponce Y; Lombardo I; Van Heertum R; Mann JJ; Foged C; Halldin C; Laruelle M
    Synapse; 1999 May; 32(2):93-109. PubMed ID: 10231129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alfentanil increases cortical dopamine D2/D3 receptor binding in healthy subjects.
    Hagelberg N; Aalto S; Kajander J; Oikonen V; Hinkka S; Någren K; Hietala J; Scheinin H
    Pain; 2004 May; 109(1-2):86-93. PubMed ID: 15082129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.